Log In
Print this Print this

Relivar (CAT 310, INT0028)

  Manage Alerts
Collapse Summary General Information
Company IntelGenx Corp.
DescriptionSublingual tablet formulation of dronabinol (delta-9-tetrahydrocannabinol, THC)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat neuropathic pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today